Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura

US6248365A · kind A · utility

Assignee

• Aventis Behring GmbH · DE

Inventors

• Jürgen Römisch · Marburg, DE
• Eric-Paul Paques · Marburg, DE
• Robert R. Bartlett · Darmstadt, DE
• Gerhard Dickneite · Marburg, DE

Key dates

• Filing date: Jul 7, 1993
• Grant date: Jun 19, 2001
• Expiry date: Jul 7, 2013

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of complement inhibitors, especially of C1 inactivator or of factors I or H, for the preparation of a pharmaceutical and for the prophylaxis and therapy of chronic inflammatory intestinal disorders, inflammatory skin disorders and purpura.